Le Lézard
Classified in: Environment, Covid-19 virus
Subject: Corporate Social Responsibility

GrafTech Announces Release of 2020 Sustainability Report


GrafTech International Ltd. (NYSE:EAF), a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel, announced today the publication of its second annual Sustainability Report. GrafTech's 2020 Sustainability Report highlights the company's annual environmental, social, and governance (ESG) performance and initiatives.

David Rintoul, GrafTech's President and Chief Executive Officer, commented, "I am pleased to present GrafTech's second annual Sustainability Report. We are proud of the progress we made across the organization during the past year and value the opportunity to share these developments with you. We are fully committed to advancing our ESG efforts across the global organization and in the communities where we operate."

Highlights of GrafTech's 2020 Sustainability Report include:

GrafTech's digital 2020 Sustainability Report is available on our website at http://www.graftech.com/sustainability. We welcome feedback on our Sustainability Report at [email protected].

About GrafTech

GrafTech International Ltd. is a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. The Company has a competitive portfolio of low-cost, ultra-high power graphite electrode manufacturing facilities, including three of the highest capacity facilities in the world. We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, a key raw material for graphite electrode manufacturing. This unique position provides us with competitive advantages in product quality and cost.

Forward-looking statements

Statements in this press release regarding the Company that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. You can identify these forward-looking statements by the use of forward-looking words such as "will," "may," "plan," "estimate," "project," "believe," "anticipate," "expect," "foresee," "intend," "should," "would," "could," "target," "goal," "continue to," "positioned to," "are confident," or the negative versions of those words or other comparable words. Certain of the risks and uncertainties to which the Company is subject are described in the "Forward Looking Statements" and "Risk Factors" in reports and statements filed by the Company with the U.S. Securities and Exchange Commission. These risks include, without limitation, the ultimate impact that the COVID-19 pandemic has on our business, results of operations, financial condition and cash flows; the possibility that we may be unable to implement our business strategies in an effective manner; the possibility that our manufacturing operations are subject to hazards; changes in, or more stringent enforcement of, health, safety and environmental regulations applicable to our manufacturing operations and facilities; and our dependence on third parties for certain construction, maintenance, engineering, transportation, warehousing and logistics services. The Company does not undertake any obligation to update or revise these forward-looking statements to reflect new events or circumstances except as required by law.


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: